戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 othyroidism, and 18% in 141 individuals with subclinical hypothyroidism.
2 anagement of subclinical hyperthyroidism and subclinical hypothyroidism.
3  1.41% (95% CI 0.04-2.78) were found to have subclinical hypothyroidism.
4 t AF in euthyroid participants or those with subclinical hypothyroidism.
5 d no apparent benefits in older persons with subclinical hypothyroidism.
6 d normal thyroid function, 15% (n = 496) had subclinical hypothyroidism, 1.6% (n = 51) had overt hypo
7 rome were at a 21% excess risk of developing subclinical hypothyroidism (adjusted HR 1.21; 95% CI 1.0
8                   These societies argue that subclinical hypothyroidism adversely affects cardiovascu
9  analysis, the odds of MCI with clinical and subclinical hypothyroidism among men was 1.02 (95% CI, 0
10  person-years of follow-up), 1958 (6.5%) had subclinical hypothyroidism and 2574 individuals (8.6%) d
11   Among 25 390 participants, 2068 (8.1%) had subclinical hypothyroidism and 648 (2.6%) had subclinica
12                                              Subclinical hypothyroidism and hyperthyroidism are diagn
13 strates approaches to managing patients with subclinical hypothyroidism and hyperthyroidism through 5
14 nty concerning the consequences of untreated subclinical hypothyroidism and hyperthyroidism, as well
15  significant association between clinical or subclinical hypothyroidism and MCI (odds ratio [OR], 0.9
16 ses have demonstrated an association between subclinical hypothyroidism and metabolic syndrome and se
17 d with a small increase in the prevalence of subclinical hypothyroidism and thyroid autoimmunity; whe
18 : subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism.
19  thyroid function within the normal range or subclinical hypothyroidism are also associated with AF.
20 id diseases--subclinical hyperthyroidism and subclinical hypothyroidism--are common clinical entities
21                    Some authors have defined subclinical hypothyroidism as a serum TSH between 5 and
22 lating hormone (TSH) 0.45 to 4.49 mIU/L, and subclinical hypothyroidism as TSH 4.5 to 19.9 mIU/L with
23 sm was defined as TSH of 0.45 to 4.49 mIU/L, subclinical hypothyroidism as TSH of 4.5 to 19.9 mIU/L,
24                                          For subclinical hypothyroidism (based on thyroid-stimulating
25 n pregnancy before 20 weeks of gestation for subclinical hypothyroidism, defined as a thyrotropin lev
26     It found adequate evidence that treating subclinical hypothyroidism does not provide clinically m
27               Specifically, individuals with subclinical hypothyroidism had an adjusted hazard ratio
28 ral small, randomized trials of treatment of subclinical hypothyroidism have been done, but the resul
29                        For participants with subclinical hypothyroidism, HRs from higher-quality stud
30  unrecognized subclinical hyperthyroidism or subclinical hypothyroidism is associated with other card
31            The use of levothyroxine to treat subclinical hypothyroidism is controversial.
32                                              Subclinical hypothyroidism is defined as an elevation in
33                                              Subclinical hypothyroidism is known to be associated wit
34                                              Subclinical hypothyroidism is more common than is overt
35                                              Subclinical hypothyroidism may be associated with depres
36                                Treatment for subclinical hypothyroidism or hypothyroxinemia beginning
37 atment of women who are identified as having subclinical hypothyroidism or hypothyroxinemia during pr
38 ewise, there were no differences between the subclinical hypothyroidism or overt hypothyroidism group
39 rolled studies of treatment in patients with subclinical hypothyroidism or subclinical hyperthyroidis
40 niversal screening of all pregnant women for subclinical hypothyroidism or thyroid autoimmunity is no
41                            For patients with subclinical hypothyroidism, recommendations for therapy
42 scuss their perspectives on whether treating subclinical hypothyroidism reduces morbidity and mortali
43  sought to evaluate the relationship between subclinical hypothyroidism (SCH) and all-cause and cardi
44 least 65 years of age and who had persisting subclinical hypothyroidism (thyrotropin level, 4.60 to 1
45                                       In the subclinical hypothyroidism trial, the median IQ score of
46                    A total of 677 women with subclinical hypothyroidism underwent randomization at a
47 quality cohort study found that treatment of subclinical hypothyroidism was associated with decreased
48 mponents were analyzed, an increased risk of subclinical hypothyroidism was associated with high bloo
49 hort of elderly people, neither clinical nor subclinical hypothyroidism was associated with MCI.
50                                 Clinical and subclinical hypothyroidism were ascertained from a medic
51                                 Clinical and subclinical hypothyroidism were associated with worse Gl
52 llow-up of 4.2 years, the incident rates for subclinical hypothyroidism were substantially higher in
53 yndrome are at a greater risk for developing subclinical hypothyroidism, while its mechanisms and tem
54                  Association of clinical and subclinical hypothyroidism with MCI.
55               An association of clinical and subclinical hypothyroidism with mild cognitive impairmen

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。